iTeos Therapeutics, Inc.

CIK 1808865 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for iTeos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2025SCHEDULE 13G/A0001104659-25-112461
Sep 8, 202515-12G0001140361-25-034293
Sep 4, 2025EFFECT9999999995-25-002827
Sep 3, 2025SCHEDULE 13D/A0001214659-25-013290
Aug 29, 202540000950170-25-112240
Aug 29, 2025S-8 POS0001140361-25-033428
Aug 29, 202540000950170-25-112238
Aug 29, 202540001193125-25-192817
Aug 29, 2025SC TO-T/A0001140361-25-033301
Aug 29, 202540000950170-25-112236
Aug 29, 2025S-8 POS0001140361-25-033433
Aug 29, 202540000950170-25-112241
Aug 29, 202540000950170-25-112235
Aug 29, 2025S-8 POS0001140361-25-033425
Aug 29, 2025POS AM0001140361-25-033424
Aug 29, 2025SC 14D9/A0001193125-25-192007
Aug 29, 202540001193125-25-192818
Aug 29, 2025S-8 POS0001140361-25-033430
Aug 29, 2025S-8 POS0001140361-25-033427
Aug 29, 202525-NSE0001354457-25-000857
Aug 29, 2025S-8 POS0001140361-25-033426
Aug 29, 20258-K0001193125-25-192031
Aug 29, 202540000950170-25-112239
Aug 15, 2025SC TO-T/A0001140361-25-031525
Aug 14, 2025SCHEDULE 13G/A0000921895-25-002283